Case Report
Accepted on 12 Dec 2024
Pulmonary sarcomatoid carcinoma coexisting with tuberculosis: a case report and literature review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1492574
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,610 articles
Articles
Original Research
Accepted on 12 Dec 2024
Autophagic flux modulates tumor heterogeneity and lineage plasticity in SCLC
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1509183
Original Research
Published on 12 Dec 2024
Descriptive analysis of durvalumab use in unresectable stage III non-small cell lung cancer in patients treated in Quebec’s University teaching hospitals
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1506172
- 140 views
Original Research
Published on 12 Dec 2024
Application of disitamab vedotin in the multiline treatment of EGFR mutation-positive lung adenocarcinoma with Her-2 overexpression
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1472545
- 114 views
Case Report
Published on 11 Dec 2024
Primary pulmonary hyalinizing clear cell carcinoma with EWSR1 gene translocation: a case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1509132
- 143 views
Case Report
Published on 11 Dec 2024
Newly emerged ROS1 rearrangement in a patient with lung adenocarcinoma following resistance to immune checkpoint inhibitors: a case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1507658
- 143 views
Case Report
Published on 11 Dec 2024
Long-term follow-up of combination therapy with pembrolizumab and anlotinib in thoracic SMARCA4-deficient undifferentiated tumor: a case report and molecular features
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1453895
- 121 views
Original Research
Accepted on 10 Dec 2024
The trends of lung cancer burden in BRICS from 1990 to 2021 and its projection to 2035
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1511530
Case Report
Accepted on 09 Dec 2024
Pleural Rosai-Dorfman Disease Complicated with Renal Clear Cell Carcinoma: A Case Report and Literature Review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1476243
Case Report
Accepted on 09 Dec 2024
RECURRENT PNEUMOTHORACES CAUSED BY A HIGH-GRADE LUNG CARCINOMA WITH TROPHOBLASTIC DIFFERENTIATION: A CASE REPORT
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1462865
Review
Published on 09 Dec 2024
Predicting lymph node metastasis of clinical T1 non-small cell lung cancer: a brief review of possible methodologies and controversies
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1422623
- 160 views
Original Research
Published on 06 Dec 2024
Pathological features of the differentiation landscape in esophageal squamous cell cancer and their correlations with prognosis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1442212
- 153 views
Perspective
Published on 05 Dec 2024
Clinical perspectives on the value of testing for STK11 and KEAP1 mutations in advanced NSCLC
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1459737
- 318 views
Case Report
Accepted on 04 Dec 2024
Penpulimab and Anlotinib in PD-L1 High-Expression Pulmonary Giant Cell Carcinoma with Cerebral Metastases: Case Report and Review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1476205
Original Research
Published on 04 Dec 2024
A diagnostic index for predicting heart rate variability decline and prognostic value in newly diagnosed non-small cell lung cancer patients
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1463805
- 182 views
Original Research
Published on 04 Dec 2024
Combined systemic immune-inflammatory index and prognostic nutritional index predicts the efficacy and prognosis of ES-SCLC patients receiving PD-L1 inhibitors combined with first-line chemotherapy
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1485849
- 116 views